{{titleBar.title}}

{{titleBar.tagline}}

 

 

Allergan to buy three companies for combined $2.4 billionAllergan to buy three companies for combined $2.4 billionhttps://www.recenter.tamu.edu/news/newstalk-texas/?Item=147192016-10-03T05:00:00Z2016-10-03T17:00:00Z

WACO - Allergan—the pharmaceutical giant—has announced a $200 million, 322,000-sf expansion of its Waco plant and plans to break ground before the end of 2016.

Allergan will buy three companies in deals valued at almost $2.4 billion as it acquires assets to complement its operations in the United States and abroad and invests more in research and development.

  • ​The company, based in Dublin, Ireland, but with a U.S. headquarters in New Jersey, has announced it will spend an estimated $1.7 billion to land Tobira Therapeutics Inc., which develops therapies for liver disease; 
  • $639 million for Vitae Pharmaceuticals, which researches skin-care products; and 
  • $50 million for Akarna Therapeutics, which also is involved in liver treatments.

Allergan has said it will hire 75 to 100 additional employees in the near future and a total of 250 by the time production peaks. More than 700 people already work at the Allergan complex on Mars Dr.

After announcing plans to expand its Waco plant, Allergan received a promise of $21 million in economic development incentives from Waco and McLennan County. 

Waco Tribune-Herald
Waco
Industrial
http://www.wacotrib.com/news/business/allergan-to-buy-three-companies-for-combined-billion/article_925e280b-6477-5f18-90cb-e07770beeb1e.htmlRead more at the {Source}

 Search NewsTalk Texas